Out-of-pocket costs from diagnostic testing after prostate cancer screening are common and rising

FHS
July 15, 2024
4:59 pm

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) diagnostic testing to establish a diagnosis.

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization,

August 28, 2023

FDA rejects MDMA as a psychedelic treatment for PTSD

The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve

August 9, 2024

GLP-1 Revolution, Non-Traditional Delivery, and Telehealth Expansion

Guy Friedman, co-founder and CEO of SteadyMD The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.